Literature DB >> 33012072

Kidney transplantation in children with CAKUT and non-CAKUT causes of chronic kidney disease: Do they have the same outcomes?

Marta Lidia Monteverde1, Marcos Paz1, Juan Pedro Ibáñez1, Alicia Beatriz Chaparro1, Veronica Solernou2, Cristian Sager3, Catalina Tessi3, Fabrizio Locane1.   

Abstract

Almost half the children who undergo kidney transplantation (KTx) have congenital abnormalities of the kidney and urinary tract (CAKUT). We compared patient, graft survival, and kidney function at last follow-up between CAKUT and non-CAKUT patients after KTx. We divided the analysis into two eras: 1988-2000 and 2001-2019. Of 923 patients, 52% had CAKUT and 48% non-CAKUT chronic kidney disease (CKD). Of the latter, 341 (77%) had glomerular disease, most frequently typical HUS (32%) and primary FSGS (27%); 102 had non-glomerular disease. CAKUT patients were more often boys, younger at KTx, transplanted more frequently preemptively, but with longer time on chronic dialysis. They had less delayed graft function (DGF) and better eGFR, but higher incidence of urinary tract infection (1 year post-KTx). In both eras, 1-, 5-, and 10-year patient survival was similar in the groups, but graft survival was better in CAKUT recipients vs those with primary glomerular and primary recurrent glomerular disease: Era 1, 92.3%, 80.7%, and 63.6% vs 86.9%, 70.6%, and 49.5% (P = .02), and 76.7%, 56.6%, and 34% (P = .0003); Era 2, 96.2%, 88%, and 73.5% vs 90.3%, 76.1%, and 61% (P = .0075) and 75.4%, 54%, and 25.2% (P < .0001), respectively. Main predictors of graft loss were DGF, late acute rejection (AR), and age at KTx in CAKUT group and disease relapse, DGF, early AR, and number of HLA mismatches in recipients with glomerular disease. Graft survival was better in CAKUT patients. DGF was the main predictor of graft loss in all groups. Disease recurrence and early AR predicted graft failure in patients with glomerular disease.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  CAKUT vs non-CAKUT; delayed graft function; graft survival; recurrence; renal transplantation; risk factor

Year:  2020        PMID: 33012072     DOI: 10.1111/petr.13763

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

1.  Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease.

Authors:  Laura F Alconcher; Alejandro Balestracci; Paula A Coccia; Angela Del C Suarez; Flavia B Ramírez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Illiana Principi; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Miguel Liern; Marta Rivas
Journal:  Pediatr Nephrol       Date:  2021-02-18       Impact factor: 3.714

2.  Clinical outcomes and temporal trends of immunological and non-immunological rare diseases in adult kidney transplant.

Authors:  Ester Gallo; Silvia Mingozzi; Alberto Mella; Fabrizio Fop; Roberto Presta; Manuel Burdese; Elena Boaglio; Maria Cristina Torazza; Roberta Giraudi; Gianluca Leonardi; Antonio Lavacca; Paolo Gontero; Omidreza Sedigh; Andrea Bosio; Aldo Verri; Caterina Dolla; Luigi Biancone
Journal:  BMC Nephrol       Date:  2021-11-17       Impact factor: 2.388

3.  Pediatric kidney transplant recipients with and without underlying structural kidney disease have a comparable risk of hospitalization associated with urinary tract infections.

Authors:  Elizabeth Spiwak; Corina Nailescu; Andrew Schwaderer
Journal:  Front Pediatr       Date:  2022-09-02       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.